Figure 4
721 × 444px
· 55.3 KB
Source Paper
Liposomal Drug Delivery against Helicobacter pylori Using Furazolidone and N-Acetyl Cysteine in Augmented Therapy.Cite This Figure
 > Source: Muhammad Irfan Alam et al. "Liposomal Drug Delivery against Helicobacter pylori Using Furazolidone and N-Ace." *Pharmaceutics*, 2024. PMID: [39339161](https://pubmed.ncbi.nlm.nih.gov/39339161/)
<figure> <img src="https://pdfs.citedhealth.com/figures/39339161/211.png" alt="Figure 3. Diffusion of mucopenetrative liposomal particles from MP1 to MP6 through 1 mm thick sigma mucin type I in a silicon tube maintained at pH 6.0 at 37 ◦C at 1, 2, and 3 hours’ time (n = 3, mean ± SD shown). Abbreviations: MP1 (neutral with Pluronic" /> <figcaption>Figure 4. Figure 3. Diffusion of mucopenetrative liposomal particles from MP1 to MP6 through 1 mm thick sigma mucin type I in a silicon tube maintained at pH 6.0 at 37 ◦C at 1, 2, and 3 hours’ time (n = 3, mean ± SD shown). Abbreviations: MP1 (neutral with Pluronic<br> Source: Muhammad Irfan Alam et al. "Liposomal Drug Delivery against Helicobacter pylori Using Furazolidone and N-Ace." <em>Pharmaceutics</em>, 2024. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/39339161/">39339161</a></figcaption> </figure>